The process development challenge for a new vaccine.
The challenges of vaccine development are not limited to identification of suitable antigens, adjuvants and delivery methods, but include regulatory, technical and manufacturing hurdles in translating a vaccine candidate to the clinic. Process development is the technological foundation that underlies the manufacture of new vaccines and is central to successful commercialization.
Buckland
Barry C
BC
Merck Research Laboratories, West Point, Pennsylvania 19486, USA. barry_buckland@merck.com
D006562:Herpes Zoster / Q000517:prevention & control; D022283:Herpesvirus Vaccines; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000517:prevention & control; D022243:Rotavirus Vaccines; D013678:Technology, Pharmaceutical; D014612:Vaccines
D022283:Herpesvirus Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines